Status:
APPROVED_FOR_MARKETING
Use of Avanta Metacarpophalangeal (MCP) Joint Implant Finger Prosthesis, Humanitarian Use Device
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Arthroplasty of the MCP Joint
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants for finger arthritis. This is NOT a research study, but rather, a requirement by the F...
Detailed Description
The purpose of this IRB approved study is to allow patients to undergo surgery with the SR™ MCP (Metacarpophalangeal) Implants. This is NOT a research study, but rather, a requirement by the FDA for h...
Eligibility Criteria
Inclusion
- patient is in need of a revision of failed MCP prosthesis(es)
- patient expects to place his/her hands under loading situations which preclude the use of an alternative implant in the painful osteo-arthritic and post traumatic arthritic MCP joint
Exclusion
- patient is not in need of a revision of a failed MCP prothesis(es)
- patient is eligible to use an alternative implant
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02244775
Last Update
September 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021